First, we examined across all participants whether the soluble phosphorylated and aggregated tau biomarkers individually and combined were associated with cognitive decline over time on the modified preclinical Alzheimer cognitive composite (mPACC5). This evidence concerns the gene MAPT and Mental deterioration.